Last reviewed · How we verify
Adjuvant: Montonide isa 51 VG — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Adjuvant: Montonide isa 51 VG (Adjuvant: Montonide isa 51 VG) — BiondVax Pharmaceuticals ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Adjuvant: Montonide isa 51 VG TARGET | Adjuvant: Montonide isa 51 VG | BiondVax Pharmaceuticals ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Adjuvant: Montonide isa 51 VG CI watch — RSS
- Adjuvant: Montonide isa 51 VG CI watch — Atom
- Adjuvant: Montonide isa 51 VG CI watch — JSON
- Adjuvant: Montonide isa 51 VG alone — RSS
Cite this brief
Drug Landscape (2026). Adjuvant: Montonide isa 51 VG — Competitive Intelligence Brief. https://druglandscape.com/ci/adjuvant-montonide-isa-51-vg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab